TrialCirculation research2014

Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.

Vasileios Karantalis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.